Cipla Ltd is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing developing and marketing wide range of branded and generic formulations and Active ...

Cipla Limited is an Indian multinational pharmaceutical company that is headquartered in Mumbai, Maharashtra. The company is primarily known for producing generic drugs for various therapeutic uses.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Revenue rose to Rs 7,073 crore. Read more. Jan 28, 2025 16:23 Cipla Q3 Net Profit Soars 49% to Rs 1,571 Crore Cipla's net profit surged 49% to Rs 1,571 crore in Q3 FY25, driven by strong revenue ...

Cipla Q3 Results: Pharmaceutical major Cipla on Tuesday reported a 49 per cent year-on-year (YoY) increase in its consolidated net profit for the December quarter (Q3 FY25) at Rs 1,574.6 crore, from ...

Cipla has been helping extend the reach of affordable life-saving HIV/AIDS medications since 2001. The company supplies antiretroviral (ARV) medicines to 64 countries by mostly participating in the ...

Cipla's stock settled 2.2% higher at ₹1,427 on Tuesday on the National Stock Exchange. The company expects to launch its breast cancer drug Abraxane, which was originally slated for a rollout in ...

Do you ever ask yourself why some company logos we see at events get stuck in our heads while others vanish quicker than invisible ink? It’s not magic, and it isn’t luck either. The truth is that they ...

The Quarterly Results page of Cipla Ltd. presents the key result items, its comparison with the sector peers and its previous 5 Quarterly Results.

Stocks To Buy Today: Intraday BUY/SELL Calls By Sumeet Bagadia On Tuesday, 18th Feb Stock Market Crashed On February 17: Why Sensex Dropped 645 Pts & Nifty Fell 204 Pts On Monday? Stock Market ...

For the first nine months of FY25, Cipla's EBITDA margin stood at 26.9%, already above its full-year guidance of 24.5% to 25.5%.